GenVec, Inc. (NASDAQ:GNVC) surges 6.74% to $2.55 on 1.90 million shares. The stock hit an intraday high and an intraday low of $2.60 and $2.35 respectively. In the last six months the stock went up over 201%. GenVec, Inc. is a clinical stage biopharmaceutical company developing gene-based therapeutic drugs and vaccines. Its lead product candidate, TNFerade biologic (TNFerade), is being developed for use in the treatment of cancer. Using GenVec’s core adenovector technology, TNFerade stimulates the production of tumor necrosis factor alpha (TNFa), a known anti-tumor protein, in cells of the tumor.
Subscribe to daily free stock newsletter by visiting: http://www.pennystockpickreport.com/.
Conexant Systems, Inc. (NASDAQ:
About http://www.pennystockpickreport.com/
Penny Stock Pick Report offers a stock newsletter on OTC, PINKSHEETS ,OTCBB, and AMEX Stocks. Our subscribers receive daily up to date stock information on midcap, smallcap penny stocks and also stocks that are traded at NASDAQ and NYSE stock exchange. If you wish to feature your organization on our website then you can contact us at the email given below.